Top 50 Health Care Startup Investors in Austria (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
SOSV
VC Fund
|
16 | United States, China, Canada | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | $50k–$5M |
|
XISTA Science Ventures
VC Fund
|
12 | Austria, Germany, France | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $552k–$20M |
|
Johann Hansmann
Angel
|
12 | Austria, United Kingdom, Germany | Seed, Angel, Pre-Seed | Software, Health Care, Fitness | $300k–$3.4M |
|
Speedinvest
VC Fund
|
12 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Artificial Intelligence | $411k–$32M |
|
PUSH VC
VC Fund
|
10 | Austria, Germany, United States | Seed, Pre-Seed, Series A | Software, Apps, Health Care | $650k–$31M |
|
Calm/Storm VC
VC Fund
|
9 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $538k–$18M |
|
austria Wirtschaftsservice (aws)
VC Fund
|
8 | Austria, Belgium | Seed, Grant, Pre-Seed | Software, Information Technology, Artificial Intelligence | $61k–$2.7M |
|
aws Gründungsfonds
VC Fund
|
8 | Austria, Germany, United States | Seed, Series A, Venture - Series Unknown | Software, SaaS, Information Technology | $1.1M–$11M |
|
The Austrian Research Promotion Agency (FFG)
VC Fund
|
7 | Austria, United States, Belgium | Grant, Seed, Pre-Seed | Software, Artificial Intelligence, Medical | $67k–$2.8M |
|
xista science ventures
VC Fund
|
7 | Austria, Slovenia | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | $552k–$20M |
|
APEX Ventures
VC Fund
|
6 | Germany, United Kingdom, Austria | Seed, Series A, Pre-Seed | Artificial Intelligence, Software, Health Care | $552k–$22M |
|
Nina Capital
VC Fund
|
5 | United States, United Kingdom, Germany | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $529k–$21M |
|
tecnet equity
VC Fund
|
5 | Austria | Seed, Series A, Venture - Series Unknown | Software, Biotechnology, Artificial Intelligence | $208k–$20M |
|
eQventure
VC Fund
|
5 | Austria, Germany, Switzerland | Seed, Series A, Series B | Software, Information Technology, Automotive | $540k–$13M |
|
MassMutual Ventures
VC Fund
|
4 | United States, Singapore, India | Series A, Series B, Seed | Financial Services, Software, Information Technology | $2.7M–$50M |
|
LANA Ventures
VC Fund
|
4 | Austria, Germany | Seed, Pre-Seed | Health Care, Medical, Software | $2.8M–$7.4M |
|
Kinled Holding
VC Fund
|
4 | United Kingdom, United States, Switzerland | Seed, Series A | Biotechnology, Health Care, Software | $594k–$40M |
|
MIG Capital
VC Fund
|
4 | Germany, France, Austria | Series A, Series B, Venture - Series Unknown | Biotechnology, Health Care, Software | $1.7M–$60M |
|
Arax Capital Partners
VC Fund
|
3 | Austria, United States | Venture - Series Unknown, Seed, Series A | Biotechnology, Software, Health Care | $271k–$10M |
|
SquareOne Venture Capital
VC Fund
|
3 | Germany, United States, Poland | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $1M–$30M |
|
Austria Wirtschaftsservice (AWS)
VC Fund
|
3 | Austria, Philippines | Seed, Pre-Seed, Grant | Medical, Machine Learning, Artificial Intelligence | $510k–$2.3M |
|
Ascend Capital Partners
VC Fund
|
3 | Finland, Israel, Austria | Series A, Seed, Series B | Health Care, Software, Medical Device | $1.5M–$12M |
|
10x Founders
VC Fund
|
3 | Germany, United States, Switzerland | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $620k–$53M |
|
FPS-Holding
VC Fund
|
3 | Austria | Seed | Biotechnology, Health Diagnostics | $420k–$1.5M |
|
Cherry Ventures
VC Fund
|
3 | Germany, United Kingdom, United States | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $1.1M–$44M |
|
Sven Jungmann
Angel
|
2 | Austria | Seed, Pre-Seed | Medical, Medical Device | |
|
SFG Steirische Wirtschaftsförderungsgesellschaft m.b.H
VC Fund
|
2 | Austria | Seed, Grant | Software, Audio, Travel | |
|
AltaIR Capital
VC Fund
|
2 | United States, Israel, Russian Federation | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $120k–$20M |
|
Wellington Partners
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $3.1M–$60M |
|
Gateway Ventures
VC Fund
|
2 | Germany, Austria, Italy | Seed, Series A | Software, Information Technology, SaaS | $1.5M–$11M |
|
Ligand Pharmaceuticals
VC Fund
|
2 | United States, Austria, Denmark | Post-IPO Debt, Corporate Round, Post-IPO Equity | Biotechnology, Medical, Health Care | $3M–$90M |
|
VP Venture Partners
VC Fund
|
2 | Austria, Switzerland | Seed | Medical, Health Diagnostics, Internet | $3M–$6.9M |
|
SkyGene
VC Fund
|
2 | Austria | Venture - Series Unknown | Medical, Health Care, Biotechnology | |
|
Frank Westermann
Angel
|
2 | Austria, Germany, United States | Seed, Series A, Angel | Wellness, Fitness, Health Care | |
|
MMC Ventures
VC Fund
|
2 | United Kingdom, United States, France | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $1.4M–$54M |
|
GreyBird Ventures
VC Fund
|
2 | United States, Germany, China | Series A, Seed | Health Care, Medical, Biotechnology | $3M–$16M |
|
MCI Capital SA
VC Fund
|
2 | Poland, United Kingdom, Germany | Series A, Venture - Series Unknown, Seed | E-Commerce, Software, Financial Services | $766k–$29M |
|
Axilium Holding
VC Fund
|
2 | Sweden, Austria | Seed, Venture - Series Unknown | Software, Human Resources, FinTech | $450k–$7.3M |
|
FREE VALLEY HOLDINGS LIMITED
VC Fund
|
2 | Austria | Seed, Series A | Medical, Analytics, Health Diagnostics | |
|
Schnidar Harald
Angel
|
2 | Austria | Seed, Angel, Pre-Seed | Software, Biopharma, Cosmetics | |
|
Biogena
VC Fund
|
2 | Austria, United States | Seed | Food and Beverage, Fitness, Wellness | |
|
Gamma Capital Partners
VC Fund
|
2 | Austria, United States, Germany | Series A, Seed | Software, Manufacturing, Information Technology | $409k–$8M |
|
Übermorgen Ventures
VC Fund
|
2 | Germany, Switzerland, Finland | Seed, Pre-Seed, Series A | Energy, Software, SaaS | $300k–$12M |
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
2 | Germany, Switzerland, United States | Seed, Series A, Pre-Seed | Software, Biotechnology, Information Technology | $790k–$31M |
|
BackBone Ventures
VC Fund
|
2 | Switzerland, Germany, Israel | Pre-Seed, Seed, Series A | Artificial Intelligence, Software, Information Technology | $578k–$105M |
|
R42 Group
VC Fund
|
2 | United Kingdom, United States, Austria | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $472k–$40M |
|
Rene Schneider
Angel
|
2 | Austria | Seed, Series A | Medical, Analytics, Health Diagnostics | |
|
Haymaker Ventures
VC Fund
|
2 | United States, Mexico, France | Series A, Seed, Pre-Seed | Financial Services, FinTech, Finance | $3.8M–$18M |
|
Longevitytech.fund
VC Fund
|
2 | United States, United Kingdom, The Netherlands | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Life Science | $100k–$10M |
|
Draper Associates
VC Fund
|
2 | United States, Canada, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Blockchain | $700k–$41M |
| Access all 358 investors in Austria Health Care startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
SOSV offers pre-seed capital and follow-on financial support to startups focusing on deep technology and scientific innovation. Founders utilize purpose-built laboratory facilities and engineering spaces to accelerate product development and testing. The firm facilitates connections between entrepreneurs and a network of investors through structured matchmaking events and technology summits.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, China, Canada
Investor stats
- Total investments: 3729
- Round size: Seed $150k–$5M; Pre-Seed $50k–$1.6M; Convertible Note $50k–$3.6M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $306M in 2023
Portfolio highlights
- Halla — Halla Intelligence is a digital solution that leverages over 100 billion shopper and product data points to recommend and promote what grocery items.
- Simply Good Jars — Simply Good Jars is a B-Corp company that delivers healthy meals in reusable + returnable packaging through use of smart refrigerated kiosks placed in offices, transit centers, universities and health-systems. Driven by purpose to change that way people think about consumption, SGJ introduces sustainable business practices into their everydayoperations with a zero-waste goal. For every jar returned back to the company for reuse, they will help feed someone in need and ensure that no packaging materials end up in landfills.
- Verdex Technologies — Verdex Technologies is an advanced materials platform technology that uses nanofibers to disrupt industries. Verdex doesn't just compete, it innovates and disrupts.
We invest in biotech and deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We are embedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Germany, France
Investor stats
- Total investments: 48
- Round size: Seed $1.8M–$6.9M; Pre-Seed $552k–$1.8M; Series A $5.7M–$20M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- PureSurf — PureSurf is a green chemistry company that develops bio-based surfactants and antimicrobial solutions for consumer and industrial markets.
- Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
- Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Johann Hansmann is based out of Vienna, Vienna and currently works as a Chairman for Hansmann Family Office. Johann previously worked at tractive as a Partner and Advisor. Johann Hansmann attended WU (Vienna University of Economics and Business).
Show more...Investment focus
- Industry: Software, Health Care, Fitness
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria, United Kingdom, Germany
Investor stats
- Total investments: 73
- Round size: Seed $300k–$3.4M; Angel $350k–$630k; Pre-Seed $439k–$2.8M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- fynk — Create, edit, negotiate and sign contracts quickly with fynk. Give your team back valuable time. Test it now for free!
- Newsrooms.ai — Newsrooms.ai is an AI-powered content production and management platform that enables businesses and news organizations to automate their whole content pipeline—from research and content generation to publishing across many digital channels.
- Donnerstag.ai — Donnerstag automates finance operations with AI: AR, AP and bank reconciliation at line-item level, exception handling and a full audit trail.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, and top-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 678
- Round size: Seed $797k–$7.9M; Pre-Seed $411k–$3.8M; Series A $4.5M–$32M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $372M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
- Polaron — Polaron connects process, structure, and performance using AI and image data to accelerate how materials are characterised, designed, and manufactured.
Early-stage VC. Pre-Seed and Seed stage. We are investing in Health- & Green Tech start-ups with singificant impact and outstanding teams.
Show more...Investment focus
- Industry: Software, Apps, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 46
- Round size: Seed $650k–$8.1M; Series A $5M–$31M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $11M in 2019
Portfolio highlights
- Voltrac — To Secure Our Borders and Food Supply.
- enspired — Revolutionize battery storage with AI-powered BESS optimization. Our energy trading platform ensures smart, real-time market access. Contact us today!
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 144
- Round size: Seed $1.3M–$6.3M; Pre-Seed $538k–$2.6M; Series A $7.6M–$18M
- Lead/follow: 8% lead, 92% follow
- Last fund: Likely still investing — raised $25M in 2023
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- aeon.life — Preventive healthcare platform that equips people with personalized insights and expert guidance for proactive whole-body health
- Health Force — Health Force develops AI agents that automate administrative and operational workflows for hospitals and clinics. The company focuses on back-office tasks such as scheduling, billing, procurement, and insurance verification. Its AI agents integrate with existing hospital systems to handle repetitive digital work and reduce manual data entry. Health Force offers its agents on a subscription basis, allowing healthcare providers to adopt automation without major software changes. The service includes an AI readiness assessment, implementation support, and continuous optimization based on observed performance. By shifting routine logistics to AI, Health Force enables healthcare staff to spend more time on direct patient-related activities.
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Grant, Pre-Seed
- Geography: Austria, Belgium
Investor stats
- Total investments: 76
- Round size: Seed $452k–$2.7M; Grant $61k–$2.3M; Pre-Seed $195k–$1.6M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $92M in 2013
Portfolio highlights
- Repentium — We strive to create
- Graph Therapeutics — Graph Therapeutics - precision immunology
- Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 100
- Round size: Seed $1.3M–$5.2M; Series A $1.1M–$11M; Venture - Series Unknown $1.9M–$3.4M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $77M in 2023
Portfolio highlights
- refinq — refinq scores every one of your locations for physical climate, nature and transition risk under IPCC scenarios, then links exposure to financial impact and adaptation actions.
- profitize — profitize is an AI‑powered financial planning and analysis (FP&A) platform built specifically for hotels and other hospitality businesses.The platform uses AI to generate forecasts, highlight risks, and provide actionable insights, positioning itself as an “FP&A co‑pilot” for hotel profitability rather than just a reporting tool.
- Invisible-Light Labs — Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals.
The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Medical
- Stage:Grant, Seed, Pre-Seed
- Geography: Austria, United States, Belgium
Investor stats
- Total investments: 75
- Round size: Seed $745k–$2.8M; Grant $67k–$2.5M; Pre-Seed $480k–$1.9M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Another Earth — Synthetic Earth observation data that trains AI models to simulate environmental change and predict risk before it happens. Vienna-based, founded 2024.
- Graph Therapeutics — Graph Therapeutics - precision immunology
- Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria, Slovenia
Investor stats
- Total investments: 22
- Round size: Seed $1.8M–$7.3M; Pre-Seed $552k–$1.5M; Series A $5.7M–$20M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- subdron — subdron turns the seabed from a blind spot into a monitored domain.
- infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, Austria
Investor stats
- Total investments: 53
- Round size: Seed $1.4M–$8M; Pre-Seed $552k–$9.1M; Series A $2.4M–$22M
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
- HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
- TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 96
- Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $52M in 2025
Portfolio highlights
- Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and better healthcare.
- Ladder Health — Expert speech, occupational, physical, and feeding therapy for children, right from home, with flexible virtual visits and a plan that fits real life.
- Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Tecnet equity is an Austrian venture capital fund investing in new technology enterprises as well as companies with innovative business ideas through venture capital. As an early-stage investor, tecnet plays an active part in the Austrian start-up landscape for many years. The support tecnet provides goes far beyond a financial investment. With personal commitment, an international business network and many years of experience, tecnet support you in making your business successful. Active in the areas of information and communication technologies (ICT), life sciences, industrial technologies, material sciences and environmental technologies, tecnet equity is providing venture capital during seed and early stages. tecnet equity further supports the management teams of its portfolio companies in developing businesses that are fit for high and sustainable growth. Tecnet also offers comprehensive support to research centres and universities in the analysis, development and marketing of research results as well as patent protection. Inventions that are of value to society are offered to companies for implementation in new products generating additional business opportunities.
Show more...Investment focus
- Industry: Software, Biotechnology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Austria
Investor stats
- Total investments: 76
- Round size: Seed $400k–$2.5M; Series A $557k–$20M; Venture - Series Unknown $208k–$3.5M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $33M in 2009
Portfolio highlights
- PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
- deepentix — Deepentix provides a graph-as-a-service platform that converts unstructured documents into verifiable claim graphs. Its software extracts semantic claims, qualifiers, constraints, and confidence information, then links entities to domain ontologies. The Claim Graph API supports natural-language and API-based queries with paragraph-level citations,conflict flags, policy checks, and provenance paths. Private extractors use domain-tuned small language models for organization-specific templates and terminology. Deepentix also offers hosted and on-premises graph deployments that can integrate with systems such as electronic laboratory notebooks, laboratory information management systems, claims systems, and chat copilots. The platform is intended for regulated workflows in life sciences, insurance, legal and regulatory work, and climate and ESG analysis where document-based decisions require traceability and audit records.
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Entrepreneurs for Entrepreneurs
Show more...Investment focus
- Industry: Software, Information Technology, Automotive
- Stage:Seed, Series A, Series B
- Geography: Austria, Germany, Switzerland
Investor stats
- Total investments: 67
- Round size: Seed $540k–$1.2M; Series A $781k–$5.6M; Series B $4.2M–$13M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Respory — Make customer behaviour visible across your store and turn real customer journeys and interactions into better retail decisions.
- 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Financial Services, Software, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, Singapore, India
Investor stats
- Total investments: 160
- Round size: Seed $2.7M–$11M; Series A $5M–$23M; Series B $7M–$50M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $150M in 2026
Portfolio highlights
- Versana — Centralized, real-time digital agent data unlocks end-to-end solutions across the $8T broadly syndicated loan and private credit markets.
- AGent Energy — AGent Energy operates a hardware and software platform that connects commercial, industrial, and institutional backup generators and other distributed energy resources to electricity markets. The company installs onsite equipment and software, monitors generator condition and utilization, and manages participation in demand-response and other gridprograms. Its platform supports remote dispatch, operational alerts, anomaly detection, compliance processes, and diagnostic data for facilities such as hospitals, manufacturers, data centers, universities, agricultural sites, retailers, and water infrastructure operators. AGent Energy shares market proceeds with participating facility owners while maintaining generator availability for backup use.
- EduFund — EduFund is India's leading education finance platform, helping parents plan, save, and pay for their child's higher education, in India or abroad. Co-founded in 2020 by Eela Dubey and Arindam Sengupta, EduFund was built on a simple conviction: most Indian families focus intensely on academic preparation for college and almost entirelyignore the financial side until it's too late. Eela Dubey, Co-founder and CEO, is a NYU graduate with a background in hedge funds on Wall Street. Arindam Sengupta, Co-founder, is a Princeton University alumnus with experience at Citadel and Reliance Capital. Together, they built EduFund to close the gap between being academically ready and financially ready for higher education. The platform offers a full suite of education finance tools, including mutual fund SIPs, fixed deposits, digital gold, and term insurance, alongside education loans, scholarship discovery, and end-to-end admissions support. Its AI-powered college cost calculator, Taara, gives parents inflation-adjusted cost estimates across 3,000+ colleges in 19+ countries in seconds, factoring in tuition, living costs, and currency risk. EduFund started out as a B2C app for consumers. EduFund's B2B platform, Vittam, serves to scale the same mission through India's MFD ecosystem, enabling wealth distributors to offer their clients a broader suite of financial products, from education loans and GIFT City funds to EB-5 global investment products and international health insurance. EduFund has served 250,000+ families and built a partner network of 40+ asset management firms and 15+ lending institutions, along with over 300 MFDs and IFA's through it's B2B vertical, Vittam. EduFund has raised $12 million in total funding, including a $6 million Series A led by Cercano Management and MassMutual Ventures. The company is also supported by angel investors.
LANA Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Austria, Germany
Investor stats
- Total investments: 5
- Round size: Seed $2.8M–$7.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- Aitiologic — A precision medicine startup providing multi-modal liquid biopsy solutions for early disease detection and targeted therapy.
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 144
- Round size: Seed $594k–$14M; Series A $1.7M–$40M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Esper — Esper is the first cloud-based platform to help governments proactively manage public policy with better data and transparency.
- Varda — Expanding the economic bounds of humankind with the world's first orbital manufacturing & reentry platform.
- Cornea Sense — CorneaSense is a medtech startup developing a non-invasive, eye-based sensing device that measures ocular surface hydration to enable early detection and monitoring of conditions such as dry eye disease and systemic health disorders. The technology aims to provide real-time, objective eye biomarkers for improved clinical diagnosis and patient care.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These funds operate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria. Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Germany, France, Austria
Investor stats
- Total investments: 98
- Round size: Series A $1.9M–$40M; Series B $1.7M–$60M; Venture - Series Unknown $5.6M–$20M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $76M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Austria, United States
Investor stats
- Total investments: 14
- Round size: Seed $687k–$1.1M; Venture - Series Unknown $271k–$10M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $88M in 2008
Portfolio highlights
- Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
- Calyxha Biotechnologies — A new perspective on inflammation
- EveliQure Biotechnologies GmbH — EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine, which is intended to protect against Shigella as well as against ETEC bacteria. Both bacterial strains cause various types of diarrheal diseases, and all attempts at development of vaccines have so far only aimed to protect against one ofthe two bacterial strains. The team led by Managing Director Gábor Somogyi has succeeded for the first time in producing a combined swallow vaccine that simultaneously protects against both bacterial strains.
We invest in B2B tech entrepreneurs who are obsessed with solving complex problems in huge markets at pre-seed and seed stage
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, Poland
Investor stats
- Total investments: 84
- Round size: Seed $1M–$7.4M; Series A $4.3M–$20M; Series B $5M–$30M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $84M in 2022
Portfolio highlights
- Procuros — More and more sales teams struggle with supplier portals. We help you integrate digitally with common supplier portals and consolidate all order documents.
- Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
- Graph Therapeutics — Graph Therapeutics - precision immunology
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Austria Wirtschaftsservice is an investment firm.
Show more...Investment focus
- Industry: Medical, Machine Learning, Artificial Intelligence
- Stage:Seed, Pre-Seed, Grant
- Geography: Austria, Philippines
Investor stats
- Total investments: 8
- Round size: Seed $751k–$2.3M; Pre-Seed $510k–$1.6M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- S2data — Revolutioniere deine Lieferkette mit intelligenter Logistik. Effiziente Transporte durch bahnbrechende Algorithmen & einzigartige Software.
- Syntropic Medical — Syntropic is a medical device company that develops novel technologies that helps for the treatment of psychiatric diseases and the improvement of cognitive abilities.
- Cycuria Therapeutics — While new therapies, such as FLT3 inhibitors and venetoclax-based regimens, have improved initial response rates, durable remissions and long-term survival
Founded by two Wall Street professionals in 2002 with the goal of making companies successful by helping them raise capital and improve their management standards. This was done by taking an active role in running these companies (at the Board level and operationally) and helping to secure strategic partnerships.Over USD 100 million in assetsgenerated from successful investments in China, and more recently in Europe. All invested funds come from our partners; no 3rd party money is managed. Since the partners are investing their own capital, they are dedicated to making their investments successful.Led by Monita Mo, one of the founders and a serial entrepreneur. Our partners have decades of experience across a wide range of industries and geographical regions. All investment partners have done business in Asia and bring an extensive network of contacts for our investments. Additionally, they have started, managed, and sold businesses and understand the challenges involved.See the need to share more developed technology to other markets, especially in China, where growth opportunities may be greater. That is why we are currently focusing on companies in Europe and other developed markets that have unique technologies that can be commercialized in their home markets, Asia, and the US.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Series A, Seed, Series B
- Geography: Finland, Israel, Austria
Investor stats
- Total investments: 19
- Round size: Seed $1.5M–$9.3M; Series A $2.4M–$12M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- DriveU.auto — Transform existing terminal tractors into autonomous vehicles. Fast ROI. Continuous operation in mixed traffic.
- Pionix — PIONIX develops EVerest, a fully featured commercial open source SW platform for charging stations. With our open platform, we will provide a broad ecosystem for EV charging that can be easily extended by the open-source community and utilized by any commercial party.PIONIX as main developer of the EVerest ecosystem offers integration andsoftware update services, cloud operations and productivity & security enhancements as subscriptions.
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 94
- Round size: Seed $2.5M–$10M; Pre-Seed $620k–$5M; Series A $6.7M–$53M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $168M in 2022
Portfolio highlights
- Logicc — Logicc provides business solutions for various industries. It specializes in software development, automation, and data-driven technologies.
- Qorelo — Qorelo is a tech company that provides agentic AI software designed to accelerate ERP transformations. Qorelo's software automates and structures deliverables across the SAP Activate methodology.
- Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
SPV
Show more...Investment focus
- Industry: Biotechnology, Health Diagnostics
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 3
- Round size: Seed $420k–$1.5M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Cherry Ventures is Europe’s leading early-stage venture capital firm led by a team of founders and operators with experience building fast-scaling companies such as Spotify, Zalando, and Uber. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from go-to-market strategy, scaling the business, and team formation across all crucial stages in their journey. We look for founders with a vision to create revolutionary technologies - whether it’s AI, healthcare, robotics, consumer, or others - that impact society and change the world for the better. Cherry has invested in the pre-seed and seed stages of over 130 companies across Europe, including Flix, Auto1, Flaschenpost, Amboss, Manual, Numa, Moss, The Exploration Company, Qualifyze, Swap, Dash0, Proxima Fusion and Tacto. Cherry has offices in Berlin, London, and Stockholm. www.cherry.vc
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 300
- Round size: Seed $1.9M–$14M; Pre-Seed $1.1M–$6.6M; Series A $7.3M–$44M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely actively investing — fresh fund, raised $500M in 2025
Portfolio highlights
- RobCo — Easily automate the repetitive tasks in your production facility with modular industrial robots from RobCo.
- Spiich Labs — AI for revenue teams that win on relationships. Spiich preps your meetings, updates your CRM and drafts follow-ups. Reps save 9+ hours every week.
- Integral — Bookkeeping, financial statements, and payroll all from one source
As a physician, I cherished every life touched, every suffering eased; yet I yearned for more - a greater, scalable social impact. I dreamt of a world where my own reach was not limited by the confines of time or distance, where every doctor could harness the power of technology to multiply their healing touch. Today, this dream takes shape throughour breath diagnostics company, where we strive to equip hundreds of thousands of doctors worldwide with our pioneering technology, thereby transforming patient care. We are crafting a future where technology and compassion converge, redefining the boundaries of what we, as physicians, can achieve for our patients.
Show more...Investment focus
- Industry: Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Flinn — We are driven to impact the health of millions of people around the globe by enabling medical companies to launch and operate products more efficiently. To make this vision come true, we established a customer-centric, experimentation-driven product development approach.
Financing for startups in Styria
Show more...Investment focus
- Industry: Software, Audio, Travel
- Stage:Seed, Grant
- Geography: Austria
Investor stats
- Total investments: 6
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- teamazing — ONLINE TEAM EVENTS, BUT AMAZING! We enthuse teams. For better teamwork and more fun at work. This leads to better products, higher profitability and happier employees. teamazing was founded in 2014 as a startup in Graz. The winning team now counts 25 employees in Graz, Vienna and Munich and specialized in online team building during the Coronacrisis. Before that, the company expanded to Germany in 2018 and became the market leader for teambuilding events in Austria in 2019.
- Busfinder.com — Reisebus mieten mit Fahrer. Bus Angebote von Busunternehmen vergleichen und online buchen. Jetzt Bus buchen auf busfinder.com
- Delphi Data Labs — Unlock your hidden market potential and use your data to its fullest potential. We offer everything from market analysis, data modelling and vizualization to system integration in your existing technical environment to super-charge your decision-making.
We foster innovation and work together to find and grow breakthroughs all over the world
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Israel, Russian Federation
Investor stats
- Total investments: 333
- Round size: Seed $125k–$6M; Pre-Seed $120k–$2M; Series A $2.1M–$20M
- Lead/follow: 15% lead, 85% follow
- Last fund: Likely still investing — raised $50M in 2024
Portfolio highlights
- Chatsimple — Deploy AI agents across sales, customer experience, and custom workflows, built around your systems and company knowledge.
- Noodle Tomato — Noodle Tomato is an AI video agent. Describe a video and get a finished one back: script, narration, visuals, music and edit. Long-form and faceless YouTube.
- Plurio — Full-Funnel Dashboards with Advanced Attribution Built Just for You
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 201
- Round size: Series A $3.1M–$36M; Series B $8.3M–$60M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $222M in 2019
Portfolio highlights
- nyra health — nyra health is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. nyra health was founded in 2020 and was headquartered in Vienna, Austria.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
- Beren Therapeutics — Founded to serve patients through transformative medicines
Gateway Ventures is Austria's biggest network of startup investors with currently over 4000 investors. We foster the Austrian and European startup eco-system by connecting investors and startups. Our startup portfolio covers FinTech, CleanTech, HeathTech, IT & Software, Big Data & Social Impact. We have financed >40 startups withseed fundings over € 30M+Gateway Ventures was founded in December 2015. Over 1000 investors and 200 partners are currently participating in the network, including European incubators, accelerators and VCs.https://www.gateway.ventures
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: Germany, Austria, Italy
Investor stats
- Total investments: 27
- Round size: Seed $1.5M–$4.5M; Series A $3.4M–$11M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Cloov — Cloov helps fashion brands integrate rental, resale, and repair services seamlessly. Our white-label platforms, powered by an embedded website builder, connect directly to our software for automatic order management, dispatch, and payment processing.
- hypt — hypt is a Swiss based SaaS marketing solution that empowers companies to digitalize word-of-mouth. By using our word-of-mouth manager companies are able to activate 40% of their customers to send out a personal recommendation to their peers increasing sales through word-of-mouth by 4 times. Our solution empowers our ICP customers in the finance andinsurance segments to strategically use and optimize the most authentic and cost effective advertising channel – word-of-mouth – and makes it an accessible asset of every marketing mix.
- SOMAREALITY — SOMAREALITY provides eye tracking solutions for diverse industries. Improve healthcare, automotive, research & aviation with real-time cognitive insights.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Post-IPO Debt, Corporate Round, Post-IPO Equity
- Geography: United States, Austria, Denmark
Investor stats
- Total investments: 19
- Round size: Post-IPO Debt $15M–$85M; Corporate Round $3M–$10M; Post-IPO Equity $15M–$90M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Agenus — Activating the Power of the Immune System to Defeat Cancer
- Zerion Pharma — Zerion Pharma is a pharmaceutical company that aims to transform the pharmaceutical landscape with a new formulation technology. The company is focused on improving existing drugs by building an internal pipeline to solve the most challenging drug solubility problems that pharmaceutical companies face. Zerion Pharma was founded in 2019 and isbased in Birkerød, Denmark.
- Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
VP Venture Partners is a venture capital firm invests in healthcare companies.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, Internet
- Stage:Seed
- Geography: Austria, Switzerland
Investor stats
- Total investments: 7
- Round size: Seed $3M–$6.9M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
- Moonlight AI — Moonlight AI was created to democratize the access to genomic information that is essential for therapy decision making in the era of personalized medicine.
- CollimateHealth — CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
SkyGene is a venture capital firm. The firm intends to invest in biotech firms.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Venture - Series Unknown
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
- Co-Founder Co-CEO of 9am.Health - Co-Founder & CEO of mySugr (acquired by Roche in 2017) - Early stage investor with focus on digital health & fin-tech
Show more...Investment focus
- Industry: Wellness, Fitness, Health Care
- Stage:Seed, Series A, Angel
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 7
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Coinpanion — Dive into the world of crypto, NFT, DeFi and metaverse with Coinpanion's smart portfolios.
- Una Health — A new tool that blends your everyday work apps into one. It's the all-in-one workspace for you and your team
- not less but better — Wellspent makes it easy to rethink whether you want to keep scrolling social media.
MMC is an early-stage venture capital fund investing in exceptional entrepreneurs across Europe.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 261
- Round size: Seed $1.4M–$10M; Series A $2.9M–$19M; Series B $10M–$54M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $129M in 2019
Portfolio highlights
- Zenithon — Zenithon is building machine learning models to provide a step change in the development and optimization of technology. The company's mission is to keep humanity on the exponential by enabling radically faster and more accurate design and optimization. Their team develops physics grounded machine learning models that make complex simulations dramatically faster, enabling more simulations, more iterations and more ways to explore what is possible.
- ABEX — Algorithmic Best Execution for Digital Assets
- Stanhope AI — Stanhope AI is a deep-tech startup based in London with a strong background in neuroscience, robotics and fintech. We are bringing Active Inference to market as a novel framework for autonomous decision-making. To contend with the challenges of contemporary AIs, our distinct approach aims to offer
GreyBird Ventures medical technology firm and invests in companies developing products for precision medicine.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: United States, Germany, China
Investor stats
- Total investments: 11
- Round size: Seed $3M–$5M; Series A $3M–$16M
- Lead/follow: 91% lead, 9% follow
Portfolio highlights
- NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
- Platomics — Platomics provides a regulatory compliant digital infrastructure and network for every laboratory to setup and run genetic tests.
- Angstrom Bio — Machine Intelligence for Human Health. We apply machine learning and novel nucleotide chemistry to the study, diagnosis, and treatment of disease.
MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically invests EUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing. MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.
Show more...Investment focus
- Industry: E-Commerce, Software, Financial Services
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Poland, United Kingdom, Germany
Investor stats
- Total investments: 61
- Round size: Seed $1.3M–$1.5M; Series A $766k–$9.6M; Venture - Series Unknown $798k–$29M
- Lead/follow: 61% lead, 39% follow
- Last fund: May invest from a new fund soon — raised $15M in 2011
Portfolio highlights
- Windeln.de — windeln.de, together with its subsidiaries, operates as an online retailer of products for babies, toddlers, children, and young mothers in Germany, Austria, Switzerland, the Czech Republic, Spain, and China. It operates through German Shop, International Shops, and Shopping Clubs segments. The company offers a range of products, including diapers,baby food, drugstore products, clothes, toys, strollers, child car seats, baby monitors, and children’s furniture.
- ANSWEAR.com — 200 fashion brands with free delivery in 24h!
- Telematics Technologies — Telematics Technologies sp. z o.o., a Polish technology company, until December 2017 operating as NaviExpert sp. z o.o. The company is a leading provider of insurance telematics and premium navigation solutions for smartphones on the Polish market. The company's portfolio also includes, among others, a system for managing fleets of vehiclesup to 3.5 tonnes called NaviExpert Telematics. In terms of telematics insurance, since 2015 Telematics Technologies has been working with PZU Group, which is one of the largest financial groups in Central and Eastern Europe. As a result of cooperation between the entities, the first offers of Usage-Based Insurance appeared on the Polish market (Safe driving with LINK4, LINK4 Cash Returns) as well as offers of accident detection and reconstruction (PZU GO). Individual customers know Telematics Technologies primarily as a navigation application provider NaviExpert. The application is available on the market under its own brand, as well as in a white label model in offers of all mobile network operators in Poland as Navigation Orange, Navigation Play, Navigation Plus, Navigation T-Mobile. Every month, the system is used by nearly 600 thousand paying users. The company creates solutions that aim to increase road safety by improving drivers' driving styles. Since 2012, the company's CEO has been Adam Bąkowski. The majority shareholder of Telematics Technologies company is Noble Fund Private Debt Fundusz Inwestycyjny Zamknięty Aktywów Niepublicznych with its registered office in Warsaw.
Axilium Holding
Show more...Investment focus
- Industry: Software, Human Resources, FinTech
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, Austria
Investor stats
- Total investments: 4
- Round size: Seed $450k–$7.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Planacy — Planacy is a modern and flexible planning platform that is built to handle a complex reality. With Planacy you will get a tailor-made platform that is adjusted just for your business needs, a platform that you can easily develop when your prerequisites changes. By smart and seamless integrations to your BI platforms from Power BI®, Qlik® orTableau®, Planacy decreases the time consuming manual and repetitive work and supports your business with a fast, safe, more collaborative and flexible process. Together with an intuitive and smooth user interface your planning process will be simpler and more fun with more time to spend on the more value creating work as a result.
- Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
- WorkNode — Worknode is shaping the future of work. With modern technology and a deep understanding of labor market dynamics, we make flexible work safe, simple, and sustainable for both individuals and companies.For individuals, Worknode enables earning and getting paid like an employee without starting a company. For businesses, we provide a digitalemployer-of-record service that streamlines the management of external talent with full compliance, transparency, and efficiency.By building the digital infrastructure for a more flexible workforce, Worknode creates new opportunities for people to shape their careers and for companies to scale with the right skills at the right time. More than a platform, Worknode is a partner in driving a modern, dynamic, and inclusive way of working.
Investment Company
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
Entrepreneur, Angel Investor, Scientist and Inventor
Show more...Investment focus
- Industry: Software, Biopharma, Cosmetics
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 7
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Biogena develops, produces & markets high-quality dietary supplements.
Show more...Investment focus
- Industry: Food and Beverage, Fitness, Wellness
- Stage:Seed
- Geography: Austria, United States
Investor stats
- Total investments: 4
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Saturo — Eine Flasche Saturo = eine vollwertige Mahlzeit mit 36 g Protein und 26 Vitaminen & Mineralstoffen. Ohne zugesetzten Zucker. Jetzt probieren.
- Mucki Protein — Mucki Protein is a beverage manufacturing company that produces and distributes a wide range of protein-based energy drinks.
- Luminous Labs GmbH — Welcome to Luminous Labs - we are one of the leading photobiomodulation and red light therapy companies in Europe. With a strong focus on research and development we are expanding the human health-span with our non-invasive technology. One photon at a time, starting with female fertility and longevity.
gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries. They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screen of mainstream players in terms of stage and/or initial investment size.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Series A, Seed
- Geography: Austria, United States, Germany
Investor stats
- Total investments: 29
- Round size: Seed $409k–$3M; Series A $1.3M–$8M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — last raise in 2010
Portfolio highlights
- Fatfoogoo — Sudos.com is a super domain system empowering your domaining workflow and automate your market sale listings.
- Infoniqa Group — The Infoniqa Group combines twenty years of IT experience and a new, trend-setting business, which enables networking advantages and which corresponds to the requirements of their customers - typically international medium and large enterprises and institutions.
- GAT Microencapsulation — OMPONG188 menjadi tempat untuk mengakses halaman resmi game online melalui link alternatif bebas IP yang banyak disukai oleh para pengguna hiburan digital.
We are an early stage VC for climate tech startups.
Show more...Investment focus
- Industry: Energy, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, Finland
Investor stats
- Total investments: 55
- Round size: Seed $2.1M–$5.9M; Pre-Seed $300k–$4.1M; Series A $2.5M–$12M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- Ecair — Ecair provides software for indoor air quality and energy management. The platform aggregates data from connected sensors to track pollutants, CO2, humidity, temperature, and particulate matter in real time. Dashboards, alerts, and APIs support building operations, facility managers, and ESG teams. Algorithms estimate exposure, flag ventilationissues, and suggest HVAC adjustments to balance comfort, health, and energy use. Reporting tools support certifications and compliance, and data exports integrate with BMS, CMMS, and data warehouses. Services include device provisioning, calibration management, and analytics consulting for multi-site portfolios.
- Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
- Hyperion Robotics — We are accelerating the transition to sustainable and automated construction with Concrete 3D Printing.
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in various sectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 781
- Round size: Seed $790k–$6.9M; Pre-Seed $841k–$2.8M; Series A $3M–$31M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $515M in 2022
Portfolio highlights
- Selfapy — Selfapy offers a therapy support tool that helps recognize negative patterns of thought and train new behavior. Selfapy is your guided, self-help online course against depression with a personal psychologist as a companion.
- Smartblue — Smartblue develops and runs software and processes to monitor and optimize zero emission energy systems. As a hardware independent specialist Smartblue delivers a software service for the maintenance, life-cycle management, production forecasting and remote control of photovoltaic and energy storage systems all together in one centralized “SmartControl” Operations and Control Center web application. We help our customers drive down overall operational cost through automation, smart failure detection and big data analysis on imminent defects.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed, Series A
- Geography: Switzerland, Germany, Israel
Investor stats
- Total investments: 74
- Round size: Seed $966k–$4M; Pre-Seed $578k–$2.8M; Series A $5M–$105M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- eternal.ag — We help greenhouses overcome labor shortages through autonomous harvesting robots so they can keep operations running, every day, at scale.
- Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
- NextBusiness — Die einfache Schweizer Buchhaltung, mit der du buchen und Rechnungen schreiben kannst. Mit der praktischen KI-Buchhaltung buchst du 58% schneller.
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Austria
Investor stats
- Total investments: 35
- Round size: Seed $754k–$8M; Pre-Seed $472k–$2M; Series A $4.2M–$40M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $5.3M in 2025
Portfolio highlights
- xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
- Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
- Cordance Medical — We are doing some work on our site. Please come back later. We'll be up and running in no time.
Rene Schneider
Show more...Investment focus
- Industry: Medical, Analytics, Health Diagnostics
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
We invest in companies that invent the future.
Show more...Investment focus
- Industry: Financial Services, FinTech, Finance
- Stage:Series A, Seed, Pre-Seed
- Geography: United States, Mexico, France
Investor stats
- Total investments: 20
- Round size: Seed $3.8M–$11M; Series A $8M–$18M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- FlexPoint — LendARR provides a digital payments platform that modernizes the way technology is bought and sold.
- Coral Care — Coral Care is a technology company for in-person specialized pediatric developmental healthcare. It aims to improve access to pediatric developmental health services from infancy to adolescence. The platform serves as a marketplace, offering a simplified path to care by matching families with Coral Care’s team of trusted, local, in-networkpediatric specialists available for in-person and in-home sessions.Coral Care’s platform provides pediatric specialists with the infrastructure needed to grow their private practices and deliver quality in-person care. The company offers administrative support and tools, content, credentialing services, and marketing services, which enable pediatric specialists to focus on care, not managing their businesses.
- Spring Labs Holdings, Inc. — Spring Labs is building an AI-native operational risk and compliance platform for financial institutions. Zanko automates post-contact operations from intake through resolution across complaints, disputes, QA, issue management, and customer operations workflows. By combining conversational intelligence, AI agents, workflow automation, and embeddedcompliance guardrails, the platform helps institutions accelerate resolution times, reduce operational overhead, surface emerging risk earlier, and maintain audit-ready execution across every customer interaction.
Investing globally in technologies extending healthy lifespans
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 56
- Round size: Seed $634k–$10M; Pre-Seed $100k–$3.6M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
- Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
- Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
Draper Associates, founded in 1985, is a seed-stage venture capital firm that helps entrepreneurs to drive their businesses to greatness. We understand that a great company takes time to build and we'd like to ensure that entrepreneurs are in for the long haul.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Blockchain
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 519
- Round size: Seed $700k–$7.2M; Series A $2.5M–$28M; Series B $5M–$41M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely actively investing — fresh fund, raised $200M in 2025
Portfolio highlights
- Wisecut AI — Wisecut is an automatic video editor based on voice recognition
- mogul club — Mogul is a real estate investment company specializing in crowdfunded commercial property investment and acquisition. Mogul can help you buy rental property and expand your investment portfolio.
- Xverse — Xverse is your go-to sovereign onchain bank and Bitcoin wallet. Buy BTC, earn yield, pay with stablecoins, and borrow against your bitcoin. Download on iOS, Android & Chrome.
Health Care Investor funding in Austria at a glance
Stats across 314 deals from 358 investors.
Access all 358 investors in Austria Health Care startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Health Care Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 358 investors investing in Austria Health Care startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!